These characteristics share notable similarities with HIT, whereby the binding of anti-PF4 Abs to complexes of PF4 and polyanionic heparin, activates platelets via their FcγRIIa, ultimately leading to thrombosis and thrombocytopenia (Fig. 1) [64]. The gene discussed is PF4; the disease is Thrombocytopenia.